2001
DOI: 10.1006/geno.2001.6662
|View full text |Cite
|
Sign up to set email alerts
|

Cloning, Pharmacology, and Tissue Distribution of G-Protein-Coupled Receptor GPR105 (KIAA0001) Rodent Orthologs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
61
0

Year Published

2003
2003
2018
2018

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 72 publications
(69 citation statements)
references
References 17 publications
8
61
0
Order By: Relevance
“…5). Collectively, these results strongly suggest that UDP-glucose released into CF-like diseased airways acts as a pro-inflammatory mediator, via stimulation of the P2Y 14 R. P2Y 14 R mRNA is expressed in human [45] and murine [46] lungs [17,46] and inflammatory cells [17][18][19][20][21], but the identity of the cell type(s) potentially sensing UDP-glucose in airway surface liquids is not known. We observed no P2Y 14 R mRNA amplification in well-differentiated primary cultures of bronchial epithelial cells (data not shown).…”
Section: Discussionmentioning
confidence: 96%
“…5). Collectively, these results strongly suggest that UDP-glucose released into CF-like diseased airways acts as a pro-inflammatory mediator, via stimulation of the P2Y 14 R. P2Y 14 R mRNA is expressed in human [45] and murine [46] lungs [17,46] and inflammatory cells [17][18][19][20][21], but the identity of the cell type(s) potentially sensing UDP-glucose in airway surface liquids is not known. We observed no P2Y 14 R mRNA amplification in well-differentiated primary cultures of bronchial epithelial cells (data not shown).…”
Section: Discussionmentioning
confidence: 96%
“…UDP-N-acetylglucosamine, and all these molecules exhibited potencies in the 0.1-1.0 mM range of concentrations. One potential caveat from this and additional early studies was that they were accomplished using overexpressed G-protein a-subunits, either with Ga 16 , which mediates coupling of essentially all GPCR to phospholipase C-b isozymes, or with the engineered protein, Ga q/i , which selectively couples G i -linked GPCR to activation of phospholipase C-b (Chambers et al, 2000;Freeman et al, 2001;Lazarowski et al, 2003;Fricks et al, 2008). Nonetheless, results from work studying the agonist selectivity of the P2Y 14 R in cell systems in which it coupled through native G i heterotrimers to promote inhibition of adenylyl cyclase confirmed the nucleotide sugar selectivity established by Chambers and coworkers; that is, UDP-glucose is the most potent agonist, but the activities of other nucleotide sugars are within an order of magnitude .…”
Section: Mechanisms Of Release and Metabolism Of Nucleotide Sugarsmentioning
confidence: 99%
“…Accordingly, it has been shown that reducing the cellular level of UDP-GlcNAc to 5% of the normal level did not affect the synthesis or secretion of N-linked glycoproteins (58). Moreover, a G protein-coupled specific cell surface receptor for UDP-Glc, P2Y 14 , was recently identified (59,60), and the release of small amounts of UDP-Glc from a variety of cultured cells into the medium was demonstrated (61). UDP-Glc was postulated as a novel autocrine and paracrine signaling molecule, although the physiological processes regulated by its widely distributed receptor remain to be clarified.…”
Section: Fig 6 a Cellular Udp-glc Deficiency Does Not Cause Xbp-1 Amentioning
confidence: 99%